COMMUNIQUÉS West-GlobeNewswire

TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference
25/07/2019
ANDOVER, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, [...]
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
25/07/2019
CARLSBAD, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to [...]
Strong clinical progress in H1 and transformative collaboration with Gilead announced
25/07/2019
First half-year financial results: Group revenues of €108.5 million Operating loss of €97.6 million Net loss of €95.9 million Cash and cash equivalents on 30 June 2019 of €1,148 million Further development of our broad [...]
Merit Medical Reports Earnings For Second Quarter of 2019
25/07/2019
Q2 2019 worldwide revenue of $255.5 million, up 13.7% as reported over Q2 2018 Q2 2019 core revenue on a comparable, constant currency basis* up 9.6% over Q2 2018 Q2 2019 GAAP EPS was $0.12, compared to $0.21 in Q2 2018 [...]
Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2019 Financial Results and Provide Corporate Updates
25/07/2019
MENLO PARK, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular diseases, today announced that it will [...]
Cytokinetics to Announce Second Quarter Results on August 8, 2019
25/07/2019
SOUTH SAN FRANCISCO, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that it is scheduled to report second quarter results on August 8, 2019 at 4:00 PM Eastern Time. [...]
Harvard Bioscience Announces Quarter Ended June 30, 2019 Financial Results
25/07/2019
- GAAP and adjusted non-GAAP revenue of $29.6 million - GAAP and adjusted non-GAAP earnings per share of $(0.01) and $0.04, respectively - 2019 guidance remains unchanged HOLLISTON, Mass., July 25, 2019 (GLOBE NEWSWIRE [...]
Acasti Pharma Comments on Trading Activity and Reaffirms No Plans to Raise Capital
25/07/2019
LAVAL, Québec, July 25, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Eko Launches ‘Eko Home,' a Cardiac Remote Monitoring Application Enabling Powerful Drug-Data Combinations to Enhance Clinical Studies and Pharmaceutical Trials
25/07/2019
Currently being used in a study by Mayo Clinic, Eko Home enhances outpatient cardiac data collection and demonstrates real world efficacy San Francisco, July 25, 2019 (GLOBE NEWSWIRE) -- Eko , a Silicon Valley-based [...]
LifeLabs partners with Maple to bring virtual care consultations for personalized testing to Canadian homes
25/07/2019
Toronto, ON, July 25, 2019 (GLOBE NEWSWIRE) -- Today, LifeLabs announced a new partnership with Maple, Canada’s leading virtual care platform which provides 24/7 on-demand instant access to doctors and other health care [...]
Natus Medical Announces NASDAQ Ticker Symbol Change to “NTUS”
25/07/2019
PLEASANTON, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central [...]
Spineway : Strengthening corporate governance appointment of two new board members
25/07/2019
Strengthening corporate governance Appointment of two new board members An Ordinary and Extraordinary General Meeting of Spineway’s shareholders met pursuant to a second notice of meeting at 10:30 a.m. on 24 July 2019 [...]
SPINEWAY : Renforcement de la gouvernance nomination de deux nouveaux administrateurs
25/07/2019
Renforcement de la gouvernance Nomination de deux nouveaux administrateurs L'Assemblée Générale Ordinaire et Extraordinaire des actionnaires de Spineway s'est réunie, sur deuxième convocation, le 24 juillet 2019 à 10h30 [...]
Guerbet: Revenue at 30 June 2019
25/07/2019
Revenue of €400.6 million for the 1 st half of the year, in line with annual targets: +2.8% at current exchange rates +1.8% at constant exchange rates Villepinte, 25 July 2019 – Guerbet (FR0000032526 GBT), a global [...]
GUERBET : Chiffre d’affaires au 30 juin 2019
25/07/2019
Chiffre d’affaires sur le 1 er semestre de 400,6 M€, conforme aux objectifs annuels: +2,8% à taux de change courant +1,8% à taux de change constant (TCC) Villepinte, le 25 juillet 2019 - Guerbet (FR0000032526 GBT), [...]
Retail Cannabis Hits Kelowna Today Through Hobo Recreational Cannabis Store
25/07/2019
Grown here and sold here; for the first time since federal legalization, Kelowna residents will now have access to locally grown cannabis products KELOWNA, British Columbia, July 25, 2019 (GLOBE NEWSWIRE) -- Hobo [...]
Abeona Therapeutics Announces Positive Interim Data from the ABO-102 Phase 1/2 Gene Therapy Clinical Trial in MPS IIIA
25/07/2019
Neurocognitive development of youngest patients preserved 12-18 months post treatment; development scores remain within range of unaffected children Robust and sustained biomarker improvement across all dose cohorts [...]
INmune Bio Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019
25/07/2019
LA JOLLA, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT-101) for the Treatment of LCA10
25/07/2019
Expect first patient dosing in second half of 2019 DUBLIN, Ireland and CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. ( [...]

Pages